Results 141 to 150 of about 312,118 (258)

Messenger RNA and Plasmid DNA Vaccines for the Treatment of Cancer. [PDF]

Vaccines (Basel)
Moseman JE, Shim D, Jeon D, Rastogi I, Schneider KM, McNeel DG.   +5 more
europepmc   +1 more source

Nanostructured Deep Eutectic Systems in Healthcare: From Bioactive Solvents to Intelligent Biointerfaces, Wearables, and AI‐Driven Design

Advanced NanoBiomed Research, EarlyView.
Beyond the green solvent paradigm, this review redefines Deep Eutectic Systems (DES) as programmable supramolecular nanoassemblies. We survey their biomedical convergence: stabilizing thermolabile mRNA to enable cold chain‐free logistics, reshaping transdermal microneedle delivery, enabling long‐term wearables via eutectogels, and utilizing Generative ...
Jeesu Moon, Min Seo Kim, Jae‐Seung Lee
wiley   +1 more source

Predicting the translation efficiency of messenger RNA in mammalian cells. [PDF]

Nat Biotechnol
Zheng D, Persyn L, Wang J, Liu Y, Ulloa-Montoya F, Cenik C, Agarwal V.   +6 more
europepmc   +1 more source

Immunogenicity and Safety of the COVID-19 Messenger RNA Vaccine Coadministered With Influenza and 23-valent Pneumococcal Polysaccharide Vaccines. [PDF]

Clin Infect Dis
Rezahosseini O, Jensen JUS, Rahimi HK, Jensen NE, Jørgensen CS, Fischer TK, Ostrowski SR, Lundgren J, Ostergaard L, Harboe ZB.   +9 more
europepmc   +1 more source

Messenger RNA vaccines as adjuncts to surgical oncology: a new era in neoplasm immunotherapy and precision medicine. [PDF]

Ann Med Surg (Lond)
Mehmood MS, Hajj F.
europepmc   +1 more source

Synthetic messenger RNA vaccines and transcriptomic dysregulation: Evidence from new-onset adverse events and cancers post-vaccination. [PDF]

World J Exp Med
Von Ranke NL, Zhang W, Anokhin P, Hulscher N, McKernan K, Mccullough P, Catanzaro J.   +6 more
europepmc   +1 more source

Beginning of a new era of synthetic messenger RNA therapeutics: Comprehensive insights on mRNA drug design, development and applications. [PDF]

Exp Biol Med (Maywood)
Heendeniya SN, Chen S, Bhatti S, Zahra QUA, Rahimizadeh K, Poudel BH, Wilton SD, Veedu RN.   +7 more
europepmc   +1 more source

Chicken Pulmonary MicroRNAs Targeting the PB2 (Segment 1) of Avian Influenza Virus

Animal Research and One Health, EarlyView.
The PB2 segment of H5N1 is essential for replication and host adaptation. We screened 200 miRNAs and identified five (gga‐miR‐17‐3p, gga‐miR‐29a‐5p, gga‐miR‐1718, gga‐miR‐16c‐5p, and gga‐miR‐1744‐5p) using thermodynamic stability of heteroduplex, seed sequence complementarity, conservation, and accessibility, offering insights into host antiviral ...
Akanksha Choudhary, Nidhishree N. S, Rakesh Kumar Pundir, Muhasin Asaf V. N, Anamika Mishra, Ashwin Ashok Raut, Megha Agarwal, Amod Kumar   +7 more
wiley   +1 more source

Current Trends in Messenger RNA Technology for Cancer Therapeutics. [PDF]

Biomater Res
Afzal A, Abbasi MH, Ahmad S, Sheikh N, Khawar MB.   +4 more
europepmc   +1 more source

Splicing of Messenger RNA Precursors

Cold Spring Harbor Symposia on Quantitative Biology, 1987
Sharp, P. A., Konarska, M. M., Grabowski, P. J., Lamond, A. I., Marciniak, R., Seiler, S. R.   +5 more
openaire   +3 more sources